See how your reported results read as versioned evidence records — linked to experiments and limitations.Know what the science actually supports before you trust the answer.
Press Enter ↵ to review claims
Explore by Goal
"Mood reflects the biology of the brain. How you feel is affected by the chemicals in the brain, and these are the same chemicals that form the basis of mood-altering drugs."
Kabashima’s profile (from the provided records) shows substantial dermatology/immunology impact via widely cited mechanistic work (e.g., skin immune activation by PGE2–EP4) and high-impact immune/skin reviews, plus involvement in major atopic dermatitis clinical research programs.
Big uncertainty: I only had full-text-style extracted details for two items you provided; for the rest, I can only responsibly assess via the metadata snippets you supplied.
Long Explanation
Author Review: Kenji Kabashima
Scope of evidence used: I only used information explicitly included in your prompt’s supplied metadata/excerpts (not external browsing). Consequently, the strength of conclusions varies by paper.
Epistemic humility / skepticism: clinical trials and reviews have different evidentiary roles; mechanistic mouse work supports causality more directly than phenotype-level clinical associations. Where your prompt didn’t provide enough experimental detail, I avoid strong mechanistic claims.
The most detailed experimental extract you supplied concerns PGE2–EP4 signaling and skin immune initiation in mice (). A separate provided item is a dermatology single-patient case report about bullous eruptive disseminated porokeratosis (BEDP), which is inherently weak for generalizable mechanism.
2) Provided “quality-style” scores across the two detailed items
These are the paper_scientific_quality_score / paper_novelty_score / paper_explanatory_depth_score fields included in your prompt’s extracted records. This is not a universal standard, but it is a consistent internal basis for comparing the two provided extracts.
What the provided record claims: PGE2 signaling via the EP4 receptor promotes Langerhans cell migration and maturation, enabling initiation of skin immune responses; EP4 deficiency impairs contact hypersensitivity.
Experimental style (causal strength): the record indicates multiple assays (RT-PCR, flow cytometry, mixed lymphocyte reactions, histology) and uses receptor knockout mouse strains (Ptger1-/-, Ptger2-/-, Ptger3-/-, Ptger4-/-). Such a convergent approach tends to support mechanistic causality more strongly than purely observational human association studies.
Knockout background/catch-all compensations can attenuate or reshape pathway effects (“compensatory mechanisms in knockout mice”).
Potential incompleteness in receptor coverage: the record highlights it “may” not fully explore other prostaglandin receptors’ roles.
4) Clinical/translation representation (examples from supplied OpenAlex metadata snippets)
Your prompt includes additional high-level bibliographic items tied to atopic dermatitis and immune biology. I can only assess them at the level of the supplied metadata/excerpts, not full experimental details.
NEJM nemolizumab (IL-31RA blockade) in atopic dermatitis: the provided record describes efficacy/safety evaluation of a humanized antibody against IL-31 receptor A. Mechanistically, IL-31 is linked to pruritus and inflammatory pathways; however, the exact effect sizes, inclusion/exclusion criteria, and adjudication methods were not provided in your prompt.
High-level immunology synthesis: “The immunological anatomy of the skin” is a review-type synthesis, which is valuable for structure and conceptual mapping but is not itself a primary causal experiment.
5) Case-report example (low mechanistic generalizability by design)
The provided 2025 BEDP case report (“Tense Bullous Eruptions Arising in Porokeratosis: A Quiz”) documents a rare presentation and differential diagnosis from bullous pemphigoid using serology/biopsy imaging and clinical response to edema reduction via compression.
Why this item has limited inference power
Single-case design makes it hard to distinguish causal from coincident effects (e.g., edema vs corticosteroid-associated changes).
No molecular/genetic mechanism is reported in the provided excerpt, so the “basal membrane abnormalities” discussion is suggestive rather than demonstrated.
6) Author scientific strength: what looks strong vs uncertain (based on supplied records)
What appears strong
Mechanistic immunology capacity: the provided EP4/Langerhans cell chain includes receptor-level hypothesis testing with multiple orthogonal assays and functional readouts.
Capacity to synthesize: leadership authorship of a major skin immune review suggests broad cross-topic understanding (though reviews are not the same as primary experimental proof).
What remains uncertain / evidence gaps
Reproducibility/robustness details are missing for most of the author’s supplied list: for example, the prompt includes at least three atopic dermatitis baricitinib/dermocorticoid tapering papers by title only, but not the experimental design, effect sizes, statistical methods, adverse event granularity, or pre-registration status in your excerpt set. (Therefore, I do not grade them as rigorously as the EP4 paper where the record includes methods/limitations fields.)
Potential context dependence: even strong mechanistic findings in mice can fail to translate fully to human skin immunology because of species differences and model-specific biology. Your EP4 extract itself flags compensatory/knockout background limitations.
7) Where this review could be falsified (what would change my view)
If independent studies fail to reproduce the EP4-dependent Langerhans cell migration/maturation → contact hypersensitivity link (or if EP4’s role is shown to be dominated by compensatory prostaglandin pathways), the mechanistic strength would drop.
If the clinical trial evidence (titled in your prompt set) shows limited effect robustness under alternative endpoints or with subgroup heterogeneity not captured in brief abstracts, translation would weaken. (No direct effect-size details were provided in your prompt, so I cannot specify which endpoint would matter most.)
Note: This is an evidence-limited review constrained by the excerpts you provided. If you upload PDFs or provide the full text/extracted methods/results for the specific phase 2b/phase 3 AD papers listed in your prompt, I can tighten rigor judgments (statistical methods, handling of missing data, multiplicity correction, effect magnitudes, and adverse-event patterns).
Feedback:
Updated: April 29, 2026
BGPT Author Review
Scientific Quality
80%
The provided mechanistic skin-immunity work (PGE2–EP4 → Langerhans migration/maturation with functional readouts) suggests genuine causal experimental thinking and multi-assay support. However, most of the author’s AD clinical items in your prompt are title-only without effect sizes/method details, and the provided case report illustrates occasional reliance on low-inference designs. Overall: strong immunodermatology influence, but I can’t fully audit rigor across the full corpus from the limited extract set.
Communication Quality
70%
From the provided records, titles and study descriptions indicate a focus on immunological mechanisms and clinical endpoints; communication likely includes standard scientific framing. But since I didn’t see abstracts/full text, I can’t grade clarity, statistical explanation quality, or how uncertainties/limitations are communicated in detail.
Author Novelty
60%
The EP4–Langerhans mechanistic chain looks like a substantive contribution, but without broader timeline mapping across the author’s full publications in your prompt, novelty is only partially evidenced. Reviews/case reports are less direct novelty generators.
Scientific Rigor
70%
The EP4 paper extract explicitly mentions receptor knockout models plus orthogonal assays and lists limitations (genetic background, compensatory effects, in vitro reliance), which is a positive rigor signal. For other listed clinical papers, I lack the statistical/method details necessary to score rigor confidently, so the overall rigor rating is moderate-high rather than maximal.
We'll email you the results when your analysis is finished.
Hypothesis Graveyard
“EP4 is universally required for all skin immune initiation across contexts.” This is unlikely because biological compensation and environmental context can shift which prostaglandin receptors dominate (suggested by knockout compensatory concerns in the provided extract).
“Edema directly causes BEDP blistering in all cases, independent of immunosuppression.” A single-case observational record can’t establish general causality, and the extract itself flags limited generalizability and lack of mechanistic tests.
Explore by Goal
Quick Explanation
Long Explanation
Top Data Sources
Ask a Follow-Up
Key Insight
Keep Exploring
Hypothesis Graveyard
Potential Experiments
Discussion